E. YETKİN Et Al. , "A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics," CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM , vol.9, no.2, pp.60-63, 2020
YETKİN, E. Et Al. 2020. A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics. CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM , vol.9, no.2 , 60-63.
YETKİN, E., TURHAN, H., ÇUĞLAN, B., & ÖZTÜRK, S., (2020). A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics. CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM , vol.9, no.2, 60-63.
YETKİN, ERTAN Et Al. "A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics," CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM , vol.9, no.2, 60-63, 2020
YETKİN, ERTAN Et Al. "A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics." CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM , vol.9, no.2, pp.60-63, 2020
YETKİN, E. Et Al. (2020) . "A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics." CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM , vol.9, no.2, pp.60-63.
@article{article, author={ERTAN YETKİN Et Al. }, title={A novel strategy to reduce the readmission rates in congestive heart failure: intermittent empirical intravenous diuretics}, journal={CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM}, year=2020, pages={60-63} }